News & Analysis on Clinical Trial Services & Contract Research And Development
Johnson & Johnson is planning to acquire TransForm Pharmaceuticals, a privately held company that specialises in the discovery of improved formulations and novel crystalline forms of drug molecules, in a cash-for-stock deal valued at around $230m...
Italy's Recordati has reported flat turnover but a rise in operating income in 2004, while its pharmaceutical chemicals business managed to return to profit, reports Phil Taylor.
Biopharmaceutical company deCODE genetics, announced the initiation of trials for a first-in-class compound used to treat atherosclerosis for which there is currently no effective drug treatment. The disease strikes almost 20 per cent of people over...
The growth in the global pharmaceutical continued to slow in 2004, with a 7 per cent hike to $550 billion, as the sector felt the effects of increased pricing pressure and the expanding market for lower-cost generic drugs, reports Phil Taylor.
The first genetic disease that affects the central nervous system has been successfully treated in an animal model, which if successfully applied to humans, could treat an entire class of diseases called lysosomal storage disorders. The disorder...
German chemicals giant BASF reported strong earnings increases across the board yesterday, helped by pricing increases. The companies activities in pharmaceuticals, part of its chemicals and fine chemicals units, also did well, report Dominique Patton...
A scanning electron microscope with the world's highest resolution has been launched, which claims previously unobtainable resolutions of 0.4nm at 30kV and 1.6nm at 1kV. The product is aimed at researchers in the pharmaceutical and food industries,...